- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 684-698 of
1,371 results
2104 Exhibit: JSN 2104 NCI Docetaxel
Document
IPR2016-01582, No. 2104-181 Exhibit - JSN 2104 NCI Docetaxel (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2055 Exhibit: JSN 2055 Scher et al, Bicalutamide for Advanced Prostate Cancer Th...
Document
IPR2016-01582, No. 2055-134 Exhibit - JSN 2055 Scher et al, Bicalutamide for Advanced Prostate Cancer The Natural Versus Treated History of Disease, J Clin Oncology, 152928 2838 1997 (P...
|
|
Cite Document
2021 Exhibit: JSN 2021 Boumpas et al, Glucocorticoid Therapy for Immune mediat...
Document
IPR2016-01582, No. 2021-102 Exhibit - JSN 2021 Boumpas et al, Glucocorticoid Therapy for Immune mediated Diseases Basic and Clinical Correlates, Ann Internal Medicine, 1191198 1208 199...
|
|
Cite Document
2159 Exhibit: JSN 2159 de Bono, JS et al, Abiraterone and increased survival in me...
Document
IPR2016-01582, No. 2159-228 Exhibit - JSN 2159 de Bono, JS et al, Abiraterone and increased survival in metastatic prostate cancer, New Engl J Med, 36419952005 2011 (P.T.A.B. Mar. 17, 20...
|
|
Cite Document
2057 Exhibit: JSN 2057 Bubley et al, Eligibility and Response Guidelines for Phase...
Document
IPR2016-01582, No. 2057-136 Exhibit - JSN 2057 Bubley et al, Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen Independent Prostate Cancer Recommendations From...
|
|
Cite Document
2106 Exhibit: JSN 2106 Orange Book Xofigo
Document
IPR2016-01582, No. 2106-183 Exhibit - JSN 2106 Orange Book Xofigo (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2100 Exhibit: JSN 2100 CDC Prostate Cancer
Document
IPR2016-01582, No. 2100-177 Exhibit - JSN 2100 CDC Prostate Cancer (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2086 Exhibit: JSN 2086 White, PC, Synthesis and Metabolism of Corticosteroids, P...
Document
IPR2016-01582, No. 2086-165 Exhibit - JSN 2086 White, PC, Synthesis and Metabolism of Corticosteroids, Principles and Practice of Endocrinology and Metabolism, Ed Kenneth L Becker, Phila...
|
|
Cite Document
2063 Exhibit: JSN 2063 Small et al, Antiandrogen Withdrawal Alone or in Combinati...
Document
IPR2016-01582, No. 2063-142 Exhibit - JSN 2063 Small et al, Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen Independent Prostate Cancer Patients A Phase I...
|
|
Cite Document
2059 Exhibit: JSN 2059 Petrylak et al, Docetaxel and Estramustine Compared with ...
Document
IPR2016-01582, No. 2059-138 Exhibit - JSN 2059 Petrylak et al, Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer, NEJM, 351...
|
|
Cite Document
2036 Exhibit: JSN 2036 Hadaschik et al, Novel targets and approaches in advance...
Document
IPR2016-01582, No. 2036-116 Exhibit - JSN 2036 Hadaschik et al, Novel targets and approaches in advanced prostate cancer, Current Opinions Urology, 17182 187 2007 (P.T.A.B. Mar. 17, 201...
|
|
Cite Document
2165 Exhibit: JSN 2165 February 11, 2014 Notice of Allowance from prosecution hi...
Document
IPR2016-01582, No. 2165-234 Exhibit - JSN 2165 February 11, 2014 Notice of Allowance from prosecution history of 438 patent (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2062 Exhibit: JSN 2062 Craft, Eplerenone Inspra, a new aldosterone antagonist for...
Document
IPR2016-01582, No. 2062-141 Exhibit - JSN 2062 Craft, Eplerenone Inspra, a new aldosterone antagonist for the treatment of systemic hypertension and heart failure, BUMC Proceedings, 1721...
|
|
Cite Document
2064 Exhibit: JSN 2064 Millikan, et al, Randomized phase 2 trial of ketoconazole an...
Document
IPR2016-01582, No. 2064-143 Exhibit - JSN 2064 Millikan, et al, Randomized phase 2 trial of ketoconazole and ketoconazoledoxorubicin in androgen independent prostate cancer, Urologic Onc...
|
|
Cite Document
2108 Exhibit: JSN 2108 Orange Book Jevtana
Document
IPR2016-01582, No. 2108-185 Exhibit - JSN 2108 Orange Book Jevtana (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
